U.S. SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C.  20549

               FORM 10-QSB -- QUARTERLY OR TRANSITIONAL REPORT
                (Added by 34-30968, eff. 8/13/93 as amended)

(Mark One)

[  x  ]  QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES 
         EXCHANGE ACT OF 1934

For the quarterly period ended JUNE 30, 1996

[     ]  TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES
         EXCHANGE ACT OF 1934

For the transition period from ___________  to ____________

Commission file number 0-17032

                           PROTEIN DATABASES, INC.
    -----------------------------------------------------------------
    (Exact name of small business issuer as specified in its charter)

    DELAWARE                                        13-3186604
-------------------------------                    ------------------
(State or other jurisdiction of                    (I.R.S. Employer
incorporation or organization                       Identification No.)

405 OAKWOOD ROAD, HUNTINGTON STATION, NEW YORK           11746
----------------------------------------------     ------------------
 (Address of principle executive offices)             (Zip Code)

  (516)-673-3939
-------------------------
Issuer's telephone number

_______________________________________________________________________
(Former name, former address and former fiscal year, if changed since
                             last report)

Check whether the issuer (1) filed all reports required to be filed by 
Section 13 or 15(d) of the Exchange Act during the past 12 months
 (or for such shorter period that the registrant was required to file
such reports) , and (2) has been subject to such filing requirements 
for the past 90 days.  Yes    No.
                        x
                       ---   ---

State the number of shares outstanding of each of the issue's classes
of common equity, as fo the latest practicable date.

          Class                                Outstanding at June 30, 1996
----------------------------                   ----------------------------
Common Stock $.01 par value                             1,459,724

<PAGE>

  PART II - OTHER INFORMATION

Item 6.  Exhibits and Reports of Form 8-K

    ( a )  Exhibits: EX-27
  
    ( b )  Reports on Form 8-K: There were no reports on Form 8-K
           filed by the Company during the three months ended
           June 30, 1996    
<PAGE>

          INDEX TO EXHIBITS

27  - FINANCIAL DATA SCHEDULE 

<PAGE>

    FINANCIAL DATA SCHEDULE     EXHIBIT 27

[DESCRIPTION] ART. 5 FDS FOR 2ND QUARTER 10-Q
[ARTICLE] 5
[LEGEND]
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
PROTEIN DATABASES, INC'S JUNE 30, 1996 FINANCIAL STATEMENTS AND IS 
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
[NAME] PROTEIN DATABASES, INC.
<TABLE>
<S>                             <C>
[PERIOD-TYPE]                   6-MOS
[FISCAL-YEAR-END]                          DEC-31-1996
[PERIOD-END]                               JUN-30-1996
[CASH]                                         280,596
[SECURITIES]                                         0
[RECEIVABLES]                                  397,614
[ALLOWANCES]                                         0
[INVENTORY]                                     44,758
[CURRENT-ASSETS]                               740,303
[PP&E]                                         991,345
[DEPRECIATION]                               (708,598)
[TOTAL-ASSETS]                               1,036,570
[CURRENT-LIABILITIES]                          158,562
[BONDS]                                              0
[PREFERRED-MANDATORY]                                0
[PREFERRED]                                          0
[COMMON]                                        14,597
[OTHER-SE]                                     863,411
[TOTAL-LIABILITY-AND-EQUITY]                 1,036,570
[SALES]                                        909,349
[TOTAL-REVENUES]                               909,349
[CGS]                                          349,089
[TOTAL-COSTS]                                1,361,236
[OTHER-EXPENSES]                                     0
[LOSS-PROVISION]                                     0
[INTEREST-EXPENSE]                                   0
[INCOME-PRETAX]                              (451,887)
[INCOME-TAX]                                         0
[INCOME-CONTINUING]                          (451,887)
[DISCONTINUED]                                       0
[EXTRAORDINARY]                                      0
[CHANGES]                                            0
[NET-INCOME]                                 (451,887)
[EPS-PRIMARY]                                    (.31)
[EPS-DILUTED]                                    (.31)
</TABLE>